CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TEVA

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
11mo
TEVAPatent Expiry
Phase 3

rasagiline mesylate Patent Expiration

rasagiline mesylate
Aug 27
Source
Competitive Landscape

2 competitors in Multiple System Atrophy

View Full Landscape
Drug Information

Target Indication

Multiple System Atrophy

Clinical Trial

NCT00977665

Last updated: 1/23/2026

Patent & Exclusivity
Expiring SoonRLD

Latest Patent Expiry

Aug 27, 2027(11 months)

Patents Listed

2

Application

NDA 021641
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.